The Lancet

Nov 12, 2020

Karyopharm Announces Publication of XPOVIO® (Selinexor) Phase 3 BOSTON Study Results in The Lancet

Mar 23, 2020

The Lancet Haematology Publishes Results From Oncopeptides' Multicenter, International Phase 1/2 Study (O-12-M1)

Nov 14, 2019

Painless Lancet Market Overview & Potential Growth Opportunities by 2024 | Key Players: LifeScan, Inc., ARKRAY, Inc. & Nipro Corporation | Radiant Insights, Inc.

Feb 19, 2019

The Lancet Publishes Phase 3 Results Demonstrating Efficacy, Safety and Tolerability of SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for Subcutaneous Use (CIII) in Patients with Moderate to Severe Opioid Use Disorder (OUD)

Jun 28, 2018

Elsevier: Preprints With The Lancet Launches on SSRN

Aug 28, 2017

ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial

Jul 25, 2017

Lancet Market Evaluated to Observe a Sharp Growth of USD 2,882.6 Million By 2022 at 11.3% of CAGR

Jul 20, 2017

The Lancet Commission: One Third of Dementia May Be Preventable

Jul 18, 2017

PTC Therapeutics Announces Publication of Data from ACT DMD in The Lancet